MADISON, Wis., June 25, 2019 – Cellular Logistics today announced the publication of an article in Nature Communications that details of a cell-production advancement with significant positive implications for the commercialization of the company’s Tandem™ technology. The article, titled Functional cardiac fibroblasts derived from human...
To read the article click here to go to the Wisconsin State Journal....
MADISON, Wis., May 7, 2019 – Cellular Logistics Inc., the UW-Madison spinoff focused on delivering new ways to treat heart failure and restore heart function, today announced the appointment of Alex Vodenlich as president and chief executive. Mr. Vodenlich also will join the company’s board...
Cellular Logistics Founder, Dr. Amish Raval, has been awarded $107,000 from the State Economic Engagement and Development (SEED) Research Program for a proposal entitled, "Bioengineered Injectable Matrix to Improve Stem Cell Retention for Heart Repair." The press release can be viewed here....
Cellular Logistics CEO Rick Soni will be one of the expert panelists talking about early stage funding pitches at the Biotechnology Entrepreneurship Bootcamp in Boston. ...
Cellular Logistics co-Founder Peiman Hematti, MD will be participating in NASA's Vascular Tissue Challenge Bioengineering Road-Mapping Summit. NASA has invited a select group of international tissue engineering experts to participate in the Summit as part of the Vascular Tissue Challenge. According to the NASA website, the...
Cellular Logistics Founder, Peiman Hematti, MD, was appointed co-chair of the Autoimmune Diseases and Cellular Therapy Working Committee for the Center for International Blood and Marrow Transplant Research. CIBMTR® is a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College...
Amish Raval, Peiman Hematti, and Eric Schmuck were recipients of the 2017 Wisconsin Alumni Research Foundation (WARF) Innovation Award. Along with John Kink, they were recognized for developing therapeutic cells for tissue-specific repair. According to the WARF press release: “An independent panel of judges selected the Innovation...
Cellular Logistics CEO Rick Soni served on the “Early-Stage Funding Pitch” panel at the Biotechnology Entrepreneurship Boot Camp at BIO 2017 in San Diego. The event highlighted the challenges that start-up biotech companies face in raising early stage capital. The Annual BIO Conference, which took...
Cellular Logistics is pleased to announce that US Patent # 9,744,265, covering the Company’s proprietary biomaterial issued on August 29, 2017. The patent may be viewed here: US Patent 9,744,265: 3-Dimensional cardiac fibroblast derived extracellular matrix About the Company: Cellular Logistics is an early stage life science...
